高级检索
卢珍珍, 姜晨晨, 倪明健, 汪宁, 彭志行. 中国艾滋病高效抗病毒治疗研究进展[J]. 中国公共卫生, 2020, 36(4): 639-642. DOI: 10.11847/zgggws1125584
引用本文: 卢珍珍, 姜晨晨, 倪明健, 汪宁, 彭志行. 中国艾滋病高效抗病毒治疗研究进展[J]. 中国公共卫生, 2020, 36(4): 639-642. DOI: 10.11847/zgggws1125584
Zhen-zhen LU, Chen-chen JIANG, Ming-jian NI, . Progress in researches on highly active antiviral therapy for AIDS in China[J]. Chinese Journal of Public Health, 2020, 36(4): 639-642. DOI: 10.11847/zgggws1125584
Citation: Zhen-zhen LU, Chen-chen JIANG, Ming-jian NI, . Progress in researches on highly active antiviral therapy for AIDS in China[J]. Chinese Journal of Public Health, 2020, 36(4): 639-642. DOI: 10.11847/zgggws1125584

中国艾滋病高效抗病毒治疗研究进展

Progress in researches on highly active antiviral therapy for AIDS in China

  • 摘要: 高效抗逆转录病毒治疗(HAART)的推广使艾滋病发展为可以控制但目前尚难以治愈的慢性传染性疾病,药物副作用、合并用药、耐药、成本收益、特殊人群的抗病毒治疗仍然是重点关注的领域。在HAART效果得到保证的前提下,扩大治疗范围有助于疫情的控制,因此在扩大抗病毒治疗的同时,如何提高抗病毒治疗质量是目前面临的挑战。

     

    Abstract: Wide application of highly active antiretroviral therapy (HAART) has led to AIDS being a controllable but currently difficult to cure chronic infectious disease. Drug side effects, combined use of drugs, drug resistance, cost-effectiveness, and antiviral therapy for special populations are still the aspects of researches focuses. Under the premise of ensuring the effect of antiviral therapy, expanding coverage of treatment is helpful to the control of epidemic situation, but how to improve the quality of antiviral therapy while expanding antiviral therapy is now a challenge.

     

/

返回文章
返回